A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris

Journal of Drugs in Dermatology

Volumn 13, Issue 1, 2014, Pages 32-38

  Jones, Terry M ^a   Jarratt, Michael T ^b   Mendez Moguel, Ines ^c   Paz, Nelly ^d   Grekin, Steven K ^e   Smith, Christina Cognata ^f   Kaur, Mandeep ^f  

^a J and S Studies Inc   (United States)

^b DermResearch Inc   (United States)

^c FXM Research International   (Belize)

^d Hospital Y Bendana   (Honduras)

^e Grekin Skin Institute   (United States)

^f Medicis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; LULICONAZOLE; 4-(2,4-DICHLOROPHENYL)-1,3-DITHIOLAN-2-YLIDENE-1-IMIDAZOLYLACETONITRILE; ANTIFUNGAL AGENT; IMIDAZOLE DERIVATIVE; OINTMENT;

ARTICLE; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; FEMALE; GASTROENTERITIS; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARASITIC GASTROENTERITIS; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCHOOL CHILD; TINEA CRURIS; TREATMENT OUTCOME; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; DRUG EFFECTS; FUNGUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; OINTMENT; TINEA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; FUNGI; HUMANS; IMIDAZOLES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OINTMENTS; TINEA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892858495     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ramam M, Prasad HR, Manchanda Y, et al. Randomised controlled trial of topical butenafine in tinea cruris and tinea corporis. Indian J Dermatol Venereol Leprol. 2003;69:154-158.
2. Pierard GE, Arrese JE, Pierard-Franchimont C. Treatment and prophylaxis of tinea infections. Drugs. 1996;52:209-224.
3. Bakos L, Brito AC, Castro LC, et al. Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris. Pediatr Infect Dis J. 1997;16:545-548.
4. Nadalo D, Montoya C, Hunter-Smith D. What is the best way to treat tinea cruris? J Fam Pract. 2006;55:256-258.
5. Lester M. Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris, and tinea corporis. Cutis, 1995;55:181-183.
6. Jordon RE, Rapini RP, Rex IH, Jr., et al. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis. Int J Dermatol. 1990;29:441-442.
7. Singal A, Pandhi D, Agrawal S, et al. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial. J Dermatolog Treat 2005;16:331-335.
8. Das S, Barbhuniya JN, Biswas I, et al. Studies on comparison of the efficacy of terbinafine 1% cream and butenafine 1% cream for the treatment of Tinea cruris. Indian Dermatol Online J. 2010;1:8-9.
9. Hart R, Bell-Syer SE, Crawford F, et al. Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ. 1999;319:79-82.
10. Bonifaz A, Saul A. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. Eur J Dermatol. 2000;10:107-109.
11. Lesher JL, Jr., Babel DE, Stewart DM, et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial. J Am Acad Dermatol. 1997;36:S20-24.
12. Saple DG, Amar AK, Ravichandran G, et al. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis). J Indian Med Assoc. 2001;99:274-275.
13. Parish LC, Parish JL, Routh HB, et al. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris. J Drugs Dermatol. 2011;10:1142-1147.
14. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002;65:2095-2102.
15. Koga H, Nanjoh Y, Inoue K, et al. In vitro activities of antifungal drugs against clinical isolates of Trichophyton tonsurans [in Japanese]. Nihon Ishinkin Gak-kai Zasshi. 2006;47:299-304.
16. Koga H, Nanjoh Y, Makimura K, et al. In vitro antifungal activities of luliconazole, a new topical imidazole. Med Mycol. 2009;47:640-647.
17. Koga H, Tsuji Y, Inoue K, et al. In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses. J Infect Chemother. 2006;12:163-165.
18. Koga H, Nanjoh Y, Kaneda H, et al. Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis. Antimicrob Agents Chemother. 2012;56:3138-3143.
19. Jarratt M, Jones T, Kempers S, et al. Luliconazole for the treatment of interdigital tinea pedis: a double-blind, vehicle-controlled study. Cutis. 2013;91:203-210.